ifosfamide and Fever
ifosfamide has been researched along with Fever in 19 studies
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Ifosfamide, Carboplatin and Etoposide (ICE) therapy was used to treat 4 patients, 2 with refractory osteosarcoma, and one each with relapsed brain tumor and newly diagnosed brain tumor." | 7.70 | [Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)]. ( Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M, 1998) |
"Our objective was to assess the efficacy of a standard dose ifosfamide and doxorubicin containing regimen in the treatment of advanced soft tissue sarcomas." | 7.70 | Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy. ( Altundağ, K; Baltali, E; Barişta, I; Celik, I; Firat, D; Güler, N; Güllü, I; Kars, A; Ozişik, Y; Tekuzman, G; Türker, A; Uner, A; Yalçin, S; Zengin, N, 2000) |
"Twenty-four patients with soft tissue or bone sarcoma who were treated with high dose ifosfamide-based chemotherapy were enrolled in this study." | 5.09 | Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcoma. ( Akbulut, H; Demirkazik, A; Dinçol, D; Içli, F; Onur, H; Pamir, A; Samur, M; Sencan, O; Senler, FC; Yalçin, B, 2000) |
"Ifosfamide, Carboplatin and Etoposide (ICE) therapy was used to treat 4 patients, 2 with refractory osteosarcoma, and one each with relapsed brain tumor and newly diagnosed brain tumor." | 3.70 | [Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)]. ( Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M, 1998) |
"Our objective was to assess the efficacy of a standard dose ifosfamide and doxorubicin containing regimen in the treatment of advanced soft tissue sarcomas." | 3.70 | Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy. ( Altundağ, K; Baltali, E; Barişta, I; Celik, I; Firat, D; Güler, N; Güllü, I; Kars, A; Ozişik, Y; Tekuzman, G; Türker, A; Uner, A; Yalçin, S; Zengin, N, 2000) |
"To investigate the feasibility and efficacy of rituximab combined with high-dose chemotherapy supported by autologous peripheral blood stem cell transplantation (ASCT) in patients with aggressive B-cell non-Hodgkin lymphoma (NHL)." | 2.74 | [A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma]. ( Cen, XN; Chen, H; Han, MZ; Han, XH; He, XH; Huang, H; Huang, HQ; Jiang, WQ; Liu, P; Ma, J; Ren, HY; Shen, XM; Shi, YK; Wang, C; Wang, JM; Yang, S; Zhou, SY; Zhu, J, 2009) |
" After adjusting for body size, AUC0-6 and Cmax were positively related to dose (P = 0." | 2.71 | Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study. ( Beane, C; Boddy, AV; Brennan, B; Chisholm, JC; Cole, M; Elsworth, AM; Errington, J; Glaser, A; Hale, J; Hemsworth, S; Howe, K; Jenner, G; McDowell, H; Nicholson, J; Parry, A; Pearson, AD; Pinkerton, R; Pritchard-Jones, K; Veal, GJ; Waters, F; Wright, Y, 2005) |
"Fever is a very rare presentation of splenic angiosarcoma." | 2.52 | Primary splenic angiosarcoma with fever and anemia: a case report and literature review. ( Chang, W; Chen, J; Deng, R; Tao, K; Wu, X; Zhang, P, 2015) |
"Paclitaxel was given at a dose of 120 mg/m2 to five patients, 135 mg/m2 to five patients, 150 mg/m2 to three patients, and 175 mg/m2 to 11 patients." | 1.29 | Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study. ( Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L, 1996) |
" For this first step a daily dosage of 300 mg/m2 of body surface resulted in only moderate leukopenia, whereas a daily dosage of 450 mg/m2 caused severe leukopenia." | 1.29 | Development of a canine chemotherapeutic model with ifosfamide. ( Chao, EY; Donehower, RC; Frassica, FJ; Ikeda, K; Inoue, N; Tomita, K, 1996) |
Research
Studies (19)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (42.11) | 18.2507 |
2000's | 9 (47.37) | 29.6817 |
2010's | 2 (10.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Deng, R | 1 |
Chang, W | 1 |
Wu, X | 1 |
Chen, J | 1 |
Tao, K | 1 |
Zhang, P | 1 |
Menzel, H | 1 |
Müller, A | 1 |
Von Schilling, C | 1 |
Licht, T | 1 |
Peschel, C | 1 |
Keller, U | 1 |
Shiu, JR | 1 |
Romanick, M | 1 |
Stobart, K | 1 |
Dincol, D | 2 |
Buyukcelik, A | 1 |
Dogan, M | 1 |
Akbulut, H | 2 |
Samur, M | 2 |
Demirkazik, A | 2 |
Senler, FC | 2 |
Onur, H | 2 |
Icli, F | 2 |
Shi, YK | 1 |
Yang, S | 1 |
Han, XH | 1 |
Ma, J | 1 |
Ren, HY | 1 |
Cen, XN | 1 |
Zhou, SY | 1 |
Wang, C | 1 |
Jiang, WQ | 1 |
Huang, HQ | 1 |
Wang, JM | 1 |
Zhu, J | 1 |
Chen, H | 1 |
Han, MZ | 1 |
Huang, H | 1 |
Shen, XM | 1 |
Liu, P | 1 |
He, XH | 1 |
Humphreys, BD | 1 |
Forman, JP | 1 |
Zandi-Nejad, K | 1 |
Bazari, H | 1 |
Seifter, J | 1 |
Magee, CC | 1 |
Veal, GJ | 1 |
Cole, M | 1 |
Errington, J | 1 |
Parry, A | 1 |
Hale, J | 1 |
Pearson, AD | 1 |
Howe, K | 1 |
Chisholm, JC | 1 |
Beane, C | 1 |
Brennan, B | 1 |
Waters, F | 1 |
Glaser, A | 1 |
Hemsworth, S | 1 |
McDowell, H | 1 |
Wright, Y | 1 |
Pritchard-Jones, K | 1 |
Pinkerton, R | 1 |
Jenner, G | 1 |
Nicholson, J | 1 |
Elsworth, AM | 1 |
Boddy, AV | 1 |
Todisco, E | 1 |
Castagna, L | 1 |
Sarina, B | 1 |
Mazza, R | 1 |
Magagnoli, M | 1 |
Balzarotti, M | 1 |
Nozza, A | 1 |
Siracusano, L | 1 |
Timofeeva, I | 1 |
Anastasia, A | 1 |
Demarco, M | 1 |
Santoro, A | 1 |
Carlson, JW | 1 |
Fowler, JM | 1 |
Saltzman, AK | 1 |
Carter, JR | 1 |
Chen, MD | 1 |
Mitchell, SK | 1 |
Dunn, D | 1 |
Carson, LF | 1 |
Adcock, LL | 1 |
Twiggs, LB | 1 |
Marina, NM | 1 |
Shema, SJ | 1 |
Bowman, LC | 1 |
Rodman, J | 1 |
Douglass, EC | 1 |
Furman, WL | 1 |
Pappo, A | 1 |
Santana, VM | 1 |
Hudson, M | 1 |
Meyer, WH | 1 |
Welte, K | 1 |
Reiter, A | 1 |
Mempel, K | 1 |
Pfetsch, M | 1 |
Schwab, G | 1 |
Schrappe, M | 1 |
Riehm, H | 1 |
Chang, AY | 1 |
Boros, L | 1 |
Garrow, GC | 1 |
Asbury, RF | 1 |
Hui, L | 1 |
Ikeda, K | 1 |
Inoue, N | 1 |
Frassica, FJ | 1 |
Donehower, RC | 1 |
Tomita, K | 1 |
Chao, EY | 1 |
Glisson, B | 1 |
Komaki, R | 1 |
Lee, JS | 1 |
Shin, DM | 1 |
Fossella, F | 1 |
Murphy, WK | 1 |
Kurie, J | 1 |
Perez-Soler, R | 1 |
Schea, R | 1 |
Vadhan-Raj, S | 1 |
Hirota, T | 1 |
Takeuchi, M | 1 |
Iwata, A | 1 |
Kitagawa, S | 1 |
Sato, T | 1 |
Konno, K | 1 |
Sawada, K | 1 |
Kobayashi, S | 1 |
Hamaguchi, N | 1 |
Agata, H | 1 |
Katano, N | 1 |
Fujimoto, T | 1 |
Theis, JG | 2 |
Chan, HS | 2 |
Greenberg, ML | 2 |
Malkin, D | 2 |
Karaskov, V | 2 |
Moncica, I | 2 |
Koren, G | 2 |
Doyle, J | 2 |
Barişta, I | 1 |
Tekuzman, G | 1 |
Yalçin, S | 1 |
Güllü, I | 1 |
Güler, N | 1 |
Ozişik, Y | 1 |
Kars, A | 1 |
Celik, I | 1 |
Türker, A | 1 |
Altundağ, K | 1 |
Zengin, N | 1 |
Uner, A | 1 |
Baltali, E | 1 |
Firat, D | 1 |
Pamir, A | 1 |
Sencan, O | 1 |
Yalçin, B | 1 |
Reviews
1 review available for ifosfamide and Fever
Article | Year |
---|---|
Primary splenic angiosarcoma with fever and anemia: a case report and literature review.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Chemotherapy, Adj | 2015 |
Trials
9 trials available for ifosfamide and Fever
Article | Year |
---|---|
Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: analysis of remission induction and stem cell mobilization.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2008 |
Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 2010 |
[A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Com | 2009 |
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study.
Topics: Adolescent; Adult; Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylat | 2005 |
CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Muri | 2007 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1996 |
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cohor | 1998 |
Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Membe | 1998 |
Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcoma.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Bone Neoplasms; Chi-Square Distribu | 2000 |
Other Studies
9 other studies available for ifosfamide and Fever
Article | Year |
---|---|
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in adolescents.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Ci | 2009 |
Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital.
Topics: Acetaminophen; Acid-Base Equilibrium; Acidosis; Adult; Analgesics, Non-Narcotic; Antineoplastic Comb | 2005 |
Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
Topics: Administration, Oral; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bacteria | 1994 |
Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Et | 1994 |
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agen | 1996 |
Development of a canine chemotherapeutic model with ifosfamide.
Topics: Animals; Antineoplastic Agents, Alkylating; Blood Platelets; Bone Neoplasms; Dogs; Drug Administrati | 1996 |
[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; | 1998 |
Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Co | 2000 |
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti | 2000 |